Octreotide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Octreotide and local guidelines before prescribing.

Somatostatin analogue

Mechanism

Somatostatin analogue.

Uses

Acromegaly, carcinoid, variceal bleeding (selected), VIPoma, high-output stoma, hypoglycaemia due to sulfonylurea overdose.

Dosing

4 more dose entries from the chapters

Side effects

Injection-site pain, diarrhoea, gallstones, hypo- or hyperglycaemia, bradycardia.

Interactions

Reduces ciclosporin levels; beta-blockers bradycardia.

Contraindications and cautions

Hypersensitivity

Monitoring

Glucose, gallbladder, IGF-1

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Ultrasound for gallstones with long-term use; insulin needs may change.

More from the textbook: uses, cautions and other points
Where it is discussed in the book